These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36227758)

  • 1. Utilization of hepatitis C virus-positive donors in kidney transplantation.
    Shetty A; Ariyamuthu VK; Gungor AB; Tanriover B
    Curr Opin Organ Transplant; 2023 Feb; 28(1):22-28. PubMed ID: 36227758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Transplantation From Hepatitis C Virus-Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update.
    Gordon CE; Adam GP; Jadoul M; Martin P; Balk EM
    Am J Kidney Dis; 2023 Oct; 82(4):410-418. PubMed ID: 37061019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience.
    Elbeshbeshy H; Modi N; Patel T; Matthews I; Kampert T; Lee J; Okeke R; Caliskan Y; Fleetwood V; Varma C; Gabris B; Bastani B; Abu Al Rub F; Guenette A; Befeler A; Agbim U; Desai R; Alsabbagh E; Qureshi K; Schnitzler M; Lentine KL; Randall HB; Nazzal M
    Clin Transplant; 2024 Jan; 38(1):e15161. PubMed ID: 37842872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
    Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
    Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Transplantation in an Elderly Veteran Population With Hepatitis C Virus Nucleic Acid Test-Positive Donors Results in Improved Outcomes After Prophylactic Glecaprevir/Pibrentasvir Therapy.
    Lopez-Soler RI; Thorndyke A; Trotter C; Zingraf G; Sorenson J; Samra M
    Transplant Proc; 2023 Mar; 55(2):317-324. PubMed ID: 36801136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
    Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM
    Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications.
    Sutcliffe S; Ji M; Chang SH; Stewart D; Axelrod DA; Lentine KL; Wellen J; Alrata L; Gupta G; Alhamad T
    Am J Transplant; 2023 May; 23(5):629-635. PubMed ID: 37130619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus.
    Yuan Q; Cui H; Leya GA; Hong S; Roth EM; Sise ME; Bethea ED; Yeh H; Williams WW; Elias N
    Transpl Int; 2021 Dec; 34(12):2562-2569. PubMed ID: 34726801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
    Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
    Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
    Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
    Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
    Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
    Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
    Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
    Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study.
    Crismale JF; Khalid M; Bhansali A; De Boccardo G; Khaim R; Florman SS; Shapiro R; Schiano TD
    Clin Transplant; 2020 Jan; 34(1):e13761. PubMed ID: 31808193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
    Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
    Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
    Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
    Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.
    Lentine KL; Peipert JD; Alhamad T; Caliskan Y; Concepcion BP; Forbes R; Schnitzler M; Chang SH; Cooper M; Bloom RD; Mannon RB; Axelrod DA
    Kidney360; 2020 Nov; 1(11):1291-1299. PubMed ID: 33251523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct-acting antiviral initiation.
    Hudson MR; Webb AR; Logan AT; Silverman A; Brueckner AJ
    Clin Transplant; 2021 Aug; 35(8):e14386. PubMed ID: 34132438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients.
    Sise ME; Chute DF; Gustafson JL; Wojciechowski D; Elias N; Chung RT; Williams WW
    Hemodial Int; 2018 Apr; 22 Suppl 1():S71-S80. PubMed ID: 29694722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.